Clozapine (Mylan Institutional Inc.)
Welcome to the PulseAid listing for the Clozapine drug offered from Mylan Institutional Inc.. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Institutional Inc. |
| NON-PROPRIETARY NAME: | clozapine |
| SUBSTANCE NAME: | CLOZAPINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Atypical Antipsychotic [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, ORALLY DISINTEGRATING |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-03-23 |
| END MARKETING DATE: | 0000-00-00 |
Clozapine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Clozapine from Mylan Institutional Inc. |
| LABELER NAME: | Mylan Institutional Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/1) |
| START MARKETING DATE: | 2017-03-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51079-212_4be46ab2-773d-4039-e054-00144ff8d46c |
| PRODUCT NDC: | 51079-212 |
| APPLICATION NUMBER: | ANDA201824 |
Other CLOZAPINE Pharmaceutical Manufacturers / Labelers:
